Search
Cataract Clinical Trials
A listing of 27 Cataract clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 27
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Cataract
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
There are currently 27 active clinical trials seeking participants for Cataract research studies. The states with the highest number of trials for Cataract participants are California, Texas, Florida and New York.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Chronic Cough Clinical Study
Recruiting
We are evaluating an investigational treatment to see if it may help people dealing with chronic cough.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Conditions:
Cough
Chronic Cough
Asthma
Allergic Asthma
Sinusitis
Featured Trial
Transcranial Magnetic Stimulation (TMS) for Obsessive Compulsive Disorder (OCD)
Recruiting
Transcranial magnetic stimulation (TMS) is an FDA-approved, non-invasive form of brain stimulation for OCD. TMS has been shown to be an effective form of treatment in individuals with OCD. By using a form of TMS termed theta-burst stimulation (TBS), we hope that this will result in a more effective treatment by producing faster symptom reduction. We are trialing a novel form of accelerated TMS, where we will deliver ten 10-minute sessions per day, for 5 days. This study will compare the efficacy of TMS for OCD at two distinct brain regions. Participants will be randomized into one of two study groups, and receive stimulation at either the DMPFC or R-OFC. Both regions have been linked to OCD by research. Patients that don't respond to their study region will have the option to receive stimulation at the other region.
Conditions:
Obsessive-Compulsive Disorder
Obsessive Compulsive Disorder
Obsessive Compulsive Disorder (OCD)
Obsessive-Compulsive Disorder (OCD)
Obsessive-compulsive Disorders and Symptoms
Featured Trial
High Triglyceride Clinical Research Study
Recruiting
Living with high triglycerides? See if our clinical study is right for you.
Don’t let financial stress hold you back. All clinical study-related assessments, care, and the investigational study drug are available at no cost. You could also be eligible for compensation for travel.
Don’t let financial stress hold you back. All clinical study-related assessments, care, and the investigational study drug are available at no cost. You could also be eligible for compensation for travel.
Conditions:
High Triglycerides
High Triglyceride Level
Hypertriglyceridemia
Elevated Triglycerides
Triglycerides High
Intraoperative OCT Guidance of Intraocular Surgery II
Recruiting
The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other microsurgeries not possible due to current limitations in surgical visualization.
Gender:
ALL
Ages:
4 weeks and above
Trial Updated:
02/03/2025
Locations: Duke University Eye Center, Durham, North Carolina
Conditions: Macular Holes, Epiretinal Membrane, Diabetic Retinopathy, Retinal Detachment, Retinal Disease, Preretinal Fibrosis, Cataract, Ocular Tumor, Strabismus, Healthy
Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations
Recruiting
The purpose of this study is to evaluate and compare the potential refractive outcomes using the Argos 1.5 biometer in the surgical planning for cataract extraction to that obtained from IOLMaster 700. Both devices are used as standard of care in surgical planning optimization for patients undergoing cataract surgery.
Gender:
ALL
Ages:
21 years and above
Trial Updated:
01/29/2025
Locations: The Eye Institute of Utah, Salt Lake City, Utah
Conditions: Cataract
IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting
The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.
Gender:
ALL
Ages:
22 years and above
Trial Updated:
01/16/2025
Locations: Trinity Research Group, LLC, Dothan, Alabama +11 locations
Conditions: Cataract, Presbyopia, Posterior Capsule Opacification
A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract Extraction
Recruiting
A Study to Evaluate the enVista® Aspire (EA) intraocular lens in Subjects Undergoing Cataract Extraction
Gender:
ALL
Ages:
22 years and above
Trial Updated:
12/06/2024
Locations: SITE 104, Dover, New Jersey +6 locations
Conditions: Cataract
Quatera 700 vs. Centurion
Recruiting
Phacoemulsification is the most common treatment for cataract surgery in the developed countries and over the years it gained importance due to several factors: small incision, surgery performed under topical anesthesia - which reduce injection-related complications - short recovery time, low post operatory induced astigmatism, and low incidence of surgical complications, when compared to the conventional surgeries. The study evaluates 2 different phacoemulsification devices in patients undergoi... Read More
Gender:
ALL
Ages:
Between 50 years and 80 years
Trial Updated:
12/02/2024
Locations: Carolina Eyecare Physicians, LLC, Mount Pleasant, South Carolina
Conditions: Cataract
Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study
Recruiting
This study is a prospective, multi-site, multi-surgeon, observational study of refractive accuracy with the Argos using BTAL after successful cataract surgery. Subjects will be assessed pre-operatively, operatively and at 5-8 weeks postoperatively. Clinical evaluations will include measurement of visual acuity, manifest refraction, and preoperative biometry.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/28/2024
Locations: Colvard-Kandavel Eye Center, Encino, California +5 locations
Conditions: Cataract
Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC
Recruiting
This is a multicenter, 2-arm, randomized, prospective study of patients slated for bilateral cataract extraction. One eye will be randomized to the Study Arm, and the fellow eye will be randomized to the Control Arm.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/26/2024
Locations: The Eye Associates - Venice, Venice, Florida +1 locations
Conditions: Cataract
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
Recruiting
This research study is evaluating the safety and efficacy (performance) of the Bausch + Lomb enVista Beyond Hydrophobic Acrylic Extended Depth of Focus Intraocular Lens (IOL) in subjects who receive this IOL in both eyes.
Gender:
ALL
Ages:
22 years and above
Trial Updated:
11/14/2024
Locations: Site 108, Northridge, California +8 locations
Conditions: Cataract
Outcomes of Clareon PanOptix in Patients With Prior Myopic Refractive Surgery
Recruiting
This study is a Single center, single arm, prospective, observational study of clinical outcomes following bilateral cataract surgery and Clareon PanOptix implantation. Subjects will be assessed preoperatively, and at 1 and 3 months postoperatively. Clinical evaluations will include administration of the QUVID and IOLSAT questionnaires, manifest refraction, topography, as well as measurement of visual acuities at distance, intermediate, and near.
Gender:
ALL
Ages:
45 years and above
Trial Updated:
11/05/2024
Locations: Juliette Eye Institute Research Center, Albuquerque, New Mexico
Conditions: Cataract
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
Recruiting
The goal of this pilot clinical trial comparing two different sedation approaches for cataract surgery is to assess patient satisfaction, the quality of recovery, and surgical outcomes as well as to evaluate the overall feasibility and acceptability of the study protocol for the purpose of planning a larger clinical trial. Participants will be asked to respond to several surveys throughout the study on their experience and to assess outcomes of interest.
Gender:
ALL
Ages:
65 years and above
Trial Updated:
10/18/2024
Locations: University of California, San Francisco, San Francisco, California
Conditions: Cataract, Bilateral Senile Cataract, Anesthesia, Patient Satisfaction
Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
Recruiting
This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.
Gender:
ALL
Ages:
50 years and above
Trial Updated:
09/10/2024
Locations: Mann Eye Institute, Houston, Texas
Conditions: Cataract
A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction
Recruiting
A study to evaluate the real-world clinical performance of the enVista Aspire and Aspire Toric intraocular lens (IOL) models EA and ETA and to assess surgeon and subject satisfaction
Gender:
ALL
Ages:
22 years and above
Trial Updated:
09/10/2024
Locations: Site 118, Birmingham, Alabama +19 locations
Conditions: Cataract
1 - 12 of 27